Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 1"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=9
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=9
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&page=9
PubPharm (3.278)
81
Study to determine the dose and safety of asciminib in pediatric patients with chronic myeloid leukemia : A multi-center, open-label study to determine the dose and safety of oral asciminib in pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia in chronic phase (Ph+ CML-CP), previously treated with one or more tyrosine kinase inhibitors
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
82
Study to determine the dose and safety of asciminib in pediatric patients with chronic myeloid leukemia : A multi-center, open-label study to determine the dose and safety of oral asciminib in pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia in chronic phase (Ph+ CML-CP), previously treated with one or more tyrosine kinase inhibitors
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
83
An Open-Label, Multicenter Study of the Safety and Efficacy in Subjects with Relapsed/Refractory Myelofibrosis and in Janus-associated Kinase Inhibitor-Intolerant Myelofibrosis : An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 with TL-895 in Subjects with Relapsed/Refractory Myelofibrosis and of KRT-232 in Janus-associated Kinase Inhibitor-Intolerant Myelofibrosis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
84
A dose escalation and expansion study of XMT-1536 en patients with solid tumors. : A Phase 1b/2, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients with Solid Tumors Likely to Express NaPi2b
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
85
A study on the safety, effectiveness and immune response of meningococcal combined ABCWY vaccine in healthy adolescents and adults : A Phase I/II, randomised, controlled study to assess the safety, effectiveness and immune response of meningococcal combined ABCWY vaccine when administered to healthy adults (Phase I) and to healthy adolescents and adults (Phase II)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
86
An open-label, multi-center, phase I/II study of MFA-370 in patients with metastatic urothelial cancer : An open-label, multi-center, phase I/II study of MFA-370 in patients with metastatic urothelial cancer - MANHATTAN
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
87
A Phase 1/2a Study to Assess AFM24 in Advanced Solid Cancers : A Phase 1/2a Open Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AFM24 in Patients with Advanced Solid Cancers
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
88
Extracorporeal photopheresis as treatment for immune related adverse events after immunotherapy : Phase 1/2 Trial to determine the safety and efficacy of Extracorporeal photopheresis as treatment for steroid-refractory immune related adverse events after immune checkpoint inhibitor therapy - ECIR (ECP for irAE)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
89
An open-label, multi-center, phase I/II study of MFA-370 in patients with metastatic urothelial cancer : An open-label, multi-center, phase I/II study of MFA-370 in patients with metastatic urothelial cancer - MANHATTAN
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
90
A study on the reactogenicity, safety, immune response, and efficacy of a vaccine against HSV-2 in healthy participants aged 18-40 years or in participants aged 18-60 years with recurrent HSV-2 genital herpes : A Phase I/II, observer-blind, randomised, placebo controlled, multi-country study to evaluate reactogenicity, safety, immune response, and efficacy of an HSV vaccine in healthy participants aged 18-40 years or in participants aged 18-60 years with recurrent HSV-2 genital herpes - TH HSV REC-003
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
[1]
« Vorheriger
4
5
6
7
8
9
10
11
12
13
14
Nächster »
[328]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 1
Medienart
3.278
Aufsätze
3.278
E-Artikel
3.278
E-Ressourcen
Zeitschriftentitel
3.278
WHO International Clinical Trials Registry Plat...
Thema
3.278
610
Phase: Phase 1
3.278
Recruitment Status: Authorised-recruitment may ...
3.278
Study Type: Interventional
26
Medical Condition: Advanced Solid Tumors MedDRA...
18
Medical Condition: B-cell Non-Hodgkin LymphomaD...
18
Medical Condition: High grade serous ovarian ca...
18
Medical Condition: Metastatic Castration-Resist...
18
Medical Condition: Relapsed or Refractory Multi...
14
Medical Condition: Huntington's Disease MedDRA ...
14
Medical Condition: KRAS p.G12C mutant advanced ...
14
Medical Condition: Melanoma MedDRA version: 21....
14
Medical Condition: Relapsed or Refractory Acute...
14
Medical Condition: The ‘wet’ form of age-re...
14
Medical Condition: pediatric CD22-positive rela...
12
Medical Condition: PMF or PPV- MF, or PET- MF M...
12
Medical Condition: Pediatric patients with Phil...
12
Medical Condition: Primary Myelofibrosis (PMF),...
12
Medical Condition: Relapsed/Refractory Myelofib...
12
Medical Condition: Solid Tumors MedDRA version:...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2.510
2020-
768
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
3.240
Englisch
34
Unbestimmt
4
Italienisch
Haven't found what you're looking for?
Wird geladen...